| __timestamp | Gilead Sciences, Inc. | Supernus Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 21102000000 | 116287000 |
| Thursday, January 1, 2015 | 28633000000 | 136004000 |
| Friday, January 1, 2016 | 26129000000 | 203017000 |
| Sunday, January 1, 2017 | 21736000000 | 287023000 |
| Monday, January 1, 2018 | 17274000000 | 393541000 |
| Tuesday, January 1, 2019 | 17774000000 | 376095000 |
| Wednesday, January 1, 2020 | 20117000000 | 467938000 |
| Friday, January 1, 2021 | 20704000000 | 504714000 |
| Saturday, January 1, 2022 | 21624000000 | 580017000 |
| Sunday, January 1, 2023 | 20618000000 | 523742000 |
| Monday, January 1, 2024 | 78200000 |
Infusing magic into the data realm
In the ever-evolving landscape of the biopharmaceutical industry, Gilead Sciences, Inc. and Supernus Pharmaceuticals, Inc. have carved distinct paths over the past decade. From 2014 to 2023, Gilead Sciences consistently demonstrated robust financial health, with gross profits peaking in 2015 at nearly 33% above their 2014 levels. Despite a dip in 2018, Gilead's profits rebounded, maintaining an average annual growth of around 2% in the latter years.
Conversely, Supernus Pharmaceuticals, though smaller in scale, showcased impressive growth, with gross profits increasing by nearly 400% from 2014 to 2023. This remarkable trajectory highlights Supernus's strategic advancements in niche markets. As the industry continues to innovate, these trends underscore the dynamic nature of biopharma, where both giants and emerging players can thrive.
Gross Profit Trends Compared: Johnson & Johnson vs Gilead Sciences, Inc.
Sanofi vs Supernus Pharmaceuticals, Inc.: A Gross Profit Performance Breakdown
Gross Profit Analysis: Comparing Gilead Sciences, Inc. and Vertex Pharmaceuticals Incorporated
Gilead Sciences, Inc. and Zoetis Inc.: A Detailed Gross Profit Analysis
Gross Profit Comparison: Gilead Sciences, Inc. and Incyte Corporation Trends
Gross Profit Analysis: Comparing Gilead Sciences, Inc. and Corcept Therapeutics Incorporated
Gross Profit Trends Compared: Gilead Sciences, Inc. vs Perrigo Company plc
Gilead Sciences, Inc. or Supernus Pharmaceuticals, Inc.: Who Manages SG&A Costs Better?
Takeda Pharmaceutical Company Limited vs Supernus Pharmaceuticals, Inc.: A Gross Profit Performance Breakdown
Incyte Corporation vs Supernus Pharmaceuticals, Inc.: A Gross Profit Performance Breakdown
Walgreens Boots Alliance, Inc. vs Supernus Pharmaceuticals, Inc.: A Gross Profit Performance Breakdown
MorphoSys AG vs Supernus Pharmaceuticals, Inc.: A Gross Profit Performance Breakdown